2017
DOI: 10.2146/ajhp151032
|View full text |Cite
|
Sign up to set email alerts
|

Optimizing proton pump inhibitor therapy for treatment of nonvariceal upper gastrointestinal bleeding

Abstract: Current guidelines recommend that PPIs be given as an i.v. bolus injection followed by a continuous infusion, but intermittent i.v. dosing and oral PPI therapy have been found to be effective in treating patients with UGIB and associated with reductions in cost.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0
4

Year Published

2017
2017
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 32 publications
0
6
0
4
Order By: Relevance
“…A study by Worden et al has shown that intermittent PPI therapy after endoscopy in higher-risk stigmata and oral PPI therapy in lower-risk patients are equally effective when compared to continuous PPI infusion in treating UGIB and this will help in reducing significant costs. Contrarily, a budget impact analysis done by Lu et al showed that the incremental costs of using different PPI regimens (continuous versus intermittent, duration) are modest (~$200) when compared to the total in-patient cost [16][17].…”
Section: Discussionmentioning
confidence: 99%
“…A study by Worden et al has shown that intermittent PPI therapy after endoscopy in higher-risk stigmata and oral PPI therapy in lower-risk patients are equally effective when compared to continuous PPI infusion in treating UGIB and this will help in reducing significant costs. Contrarily, a budget impact analysis done by Lu et al showed that the incremental costs of using different PPI regimens (continuous versus intermittent, duration) are modest (~$200) when compared to the total in-patient cost [16][17].…”
Section: Discussionmentioning
confidence: 99%
“…Omeprazole is available in both oral and injectable forms (Worden and Hanna, 2017) and has few side effects (Schubert, 2017). Although less common, the injectable form is an effective means of gastric ulcer treatment and gastric acidification inhibition (Worden and Hanna, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…Hal ini masih menjadi perdebatan, manakah yang lebih superior untuk mengatasi perdarahan saluran cerna akut (Gambar 6). 14,15 Gambar 6. Algoritma Tatalaksana Perdarahan GIT selama terapi ACS Pada pasien yang mengalami perdarahan saluran cerna yang mendapat terapi antiplatelet, hemostasis endoskopi merupakan pilihan yang direkomendasikan untuk mengurangi angka morbiditas dan mortalitas.…”
Section: Vol 41 No 3 2018 Pendahuluanunclassified